• Profile
Close

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Liver International Dec 06, 2020

Yamamura S, Eslam M, Kawaguchi T, et al. - In this investigation involving 765 Japanese patients with fatty liver (median age 54 years), researchers sought to compare the diagnostic accuracy of the metabolic associated fatty liver disease (MAFLD) definition compared to the existing NAFLD criteria to identify patients with significant fibrosis and to describe the effect of mild alcohol intake. It was noted that 79.6% and 70.7% of the 765 patients were diagnosed with MAFLD and NAFLD, respectively. In MAFLD, liver stiffness was higher relative to NAFLD. In logistic regression, MAFLD, alcohol intake, and NAFLD were independently linked to significant fibrosis. The MAFLD description best defines a group with fatty liver and significant fibrosis evaluated by non‐invasive tests. In addition, even mild alcohol consumption is linked with worsening of hepatic fibrosis measures in patients with MAFLD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay